Simon Cool received his BSc (hons) and PhD degrees from the University of Queensland in Brisbane, Australia, where he subsequently held a faculty position in the School of Biomedical Sciences. He joined A*STAR’s Institute of Molecular and Cell Biology (IMCB) in 2003 as a Principal Investigator, followed by A*STAR’s Institute of Medical Biology (IMB) in 2008, shortly after its inception. In October 2020, Cool returned to IMCB as a Research Director. He leads the Glycotherapeutics Group, where he is focused on developing novel glycosaminoglycan biomolecules that enhance wound repair and control adult human mesenchymal stem cell activity. Cool is an Adjunct Professor (Research) in the Orthopaedic Department at the National University of Singapore. He has filed over 50 patent applications and he serves as Section Editor for the Journal of Molecular Histology, and on the editorial boards of Biomaterials, and Stem Cells and Development. Cool is also Treasurer of the Tissue Engineering and Regenerative Medicine International Society (TERMIS), Asia Pacific Chapter and Vice-Treasurer of the Stem Cell Society Singapore (SCSS).
